Homologous recombination repair (HRR) alterations may be passenger events in patients with advanced prostate cancer (PC) with high tumor mutational burden (hTMB).

Autor: Bhatlapenumarthi, Vineel, De Sarkar, Navonil, Patwari, Anannya, Antonarakis, Emmanuel S., Nelson, Ariel Ann, Kilari, Deepak
Zdroj: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p206-206, 235p
Databáze: Supplemental Index